Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Drug Discovery Informatics Market
Drug Discovery Informatics Market Trends
- Report ID: GMI12667
- Published Date: Dec 2024
- Report Format: PDF
Drug Discovery Informatics Market Trends
The rising prevalence of chronic disorders coupled with technological advancement in drug discovery informatics is a significant driver of the drug discovery services.
- The increasing volume of biological data from genomics, proteomics, and other -omics sciences requires sophisticated analytics tools to generate actionable insights. Additionally, big data analytics enables the integration of diverse datasets, leading to precise biomarker identification and personalized medicine approaches.
- Moreover, these tools optimize clinical trials by identifying appropriate patient populations, reducing trial durations by 15–20%. Thus, the growing use of digital tools such as big data analytics and cloud computing enhances the precision of drug candidate selection, that is anticipated to boost market growth.
- Thus, technological advancements such as AI, big data, cloud computing, and other discovery tools are accelerating drug discovery processes by reducing costs, improving efficiency, and enhancing accuracy which is driving market growth.
Frequently Asked Questions (FAQ) :
The drug discovery informatics industry was valued at USD 3.5 billion in 2024 and is estimated to grow at an 11.5% CAGR from 2025 to 2034, driven by increased R&D investments in oncology, infectious diseases, and personalized medicine.
The software segment recorded USD 2.2 billion in 2024 and is expected to grow further as advanced software solutions are critical for managing large datasets and integrating multi-omics data in complex drug discovery processes.
The U.S. drug discovery informatics market was valued at USD 1.4 billion in 2024, driven by the rising prevalence of chronic disorders and significant investments in personalized medicine, genomics, and biologics.
Key players in the market include Accenture, Agilent Technologies, Albany Molecular Research, Boehringer Ingelheim International, Charles River Laboratories, Collaborative Drug Discovery, Eurofins Scientific, Illumina, Jubilant Life Sciences, Novo Informatics, and Oracle Corporation.
Drug Discovery Informatics Market Scope
×
Get a free sample of
Drug Discovery Informatics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below